I.S.K.A. LATIN AMERICA

I.S.K.A. AMERICA LATINA - THE NETWORK FOR FIGHTERS AND SPORT KARATE.

The new transportation technology enhanced cardiac stem cells repair

Recently, at the 2014 American Heart Association Scientific Sessions in Chicago, scientists from the Mount Sinai School of Medicine study found that after an individual for the treatment of heart attack using stem cells to repair therapy provides a new way of thinking; this study, we pre-clinical models by inducing a heart attack, followed by stem cell factor gene transfer directly transported to damage heart tissue regeneration and repair capability to detect tissue damage. Novel stem cell factor gene transfer transport system can make c-Kit positive cardiac stem cells into the body, and expansion of occurrence of aggregation, and thus to the site of injury to the heart of a heart attack caused by the reversal of heart damage. CUSABIO provide customers with reliable, high-quality experimental data and the complete Human C-Peptide ELISA Kit( http://www.cusabio.com/ELISA_Kit-72512/ ).

C-Kit positive cells in heart cells is a key factor or receptor, which may be combined with stem cell factor, which in the natural state after myocardial infarction, the heart may be increased by the restoration of cell proliferation ways. This paper studies reveal, stem cell factor gene transfer strategy can be a potential of adult stem cells to the site of cardiac injury transferred to improve cardiac pump function of the heart and reduce the risk of myocardial infarction. And the study also revealed a small number of adult stem cells can be used to repair heart damage in the area and improve the prognosis of patients theories provide new evidence.

Finally, the researchers say, heart disease has been the main cause of death of Americans, research articles intervention strategies for the development of cardiomyopathy to suppress the deterioration of heart failure provides a new hope, the researchers conducted a joint study with Celladon company now aims in the development AAV1 / SERCA2a gene therapy to treat heart failure.

Vistas: 11

Comentario

¡Tienes que ser miembro de I.S.K.A. LATIN AMERICA para agregar comentarios!

© 2024   Creada por Grandmaster Carlos Silva.   Con tecnología de

Insignias  |  Informar un problema  |  Términos de servicio